Menu
GeneBe

10-110812700-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001134363.3(RBM20):c.2303C>T(p.Ser768Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,551,660 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 6/7 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S768W) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0053 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00077 ( 4 hom. )

Consequence

RBM20
NM_001134363.3 missense

Scores

4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.958
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007951826).
BP6
Variant 10-110812700-C-T is Benign according to our data. Variant chr10-110812700-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 43988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-110812700-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00535 (814/152236) while in subpopulation AFR AF= 0.0178 (738/41536). AF 95% confidence interval is 0.0167. There are 4 homozygotes in gnomad4. There are 394 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd at 811 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RBM20NM_001134363.3 linkuse as main transcriptc.2303C>T p.Ser768Leu missense_variant 9/14 ENST00000369519.4
RBM20XM_017016103.3 linkuse as main transcriptc.2138C>T p.Ser713Leu missense_variant 9/14
RBM20XM_017016104.3 linkuse as main transcriptc.1919C>T p.Ser640Leu missense_variant 9/14
RBM20XM_047425116.1 linkuse as main transcriptc.1919C>T p.Ser640Leu missense_variant 9/14

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RBM20ENST00000369519.4 linkuse as main transcriptc.2303C>T p.Ser768Leu missense_variant 9/141 NM_001134363.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00533
AC:
811
AN:
152118
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00335
GnomAD4 exome
AF:
0.000769
AC:
1076
AN:
1399424
Hom.:
4
Cov.:
32
AF XY:
0.000697
AC XY:
481
AN XY:
690226
show subpopulations
Gnomad4 AFR exome
AF:
0.0181
Gnomad4 AMR exome
AF:
0.00134
Gnomad4 ASJ exome
AF:
0.0000794
Gnomad4 EAS exome
AF:
0.0000839
Gnomad4 SAS exome
AF:
0.0000379
Gnomad4 FIN exome
AF:
0.000203
Gnomad4 NFE exome
AF:
0.000343
Gnomad4 OTH exome
AF:
0.00107
GnomAD4 genome
AF:
0.00535
AC:
814
AN:
152236
Hom.:
4
Cov.:
32
AF XY:
0.00529
AC XY:
394
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.0178
Gnomad4 AMR
AF:
0.00301
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00812
Hom.:
65
Bravo
AF:
0.00629

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 17, 2012p.Trp768Leu in Exon 09 of RBM20: This variant is not expected to have clinical s ignificance because it has been identified in 2.6% (18/702) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs1417635). -
Benign, criteria provided, single submitterclinical testingGeneDxMay 12, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 30, 2023Variant summary: RBM20 c.2303C>T (p.Ser768Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 156550 control chromosomes. The observed variant frequency is approximately 46 fold of the estimated maximal expected allele frequency for a pathogenic variant in RBM20 causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is benign. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Dilated cardiomyopathy 1DD Benign:3
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 04, 2022- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioJun 29, 2016- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 17, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_noAF
Benign
-0.85
Cadd
Benign
8.9
MetaRNN
Benign
0.0080
T
Sift4G
Benign
0.33
T
Vest4
0.11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1417635; hg19: chr10-112572458; API